Skip to main content
Start of content

ENVI Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

Standing Committee on Environment and Sustainable Development (ENVI)
44th Parliament, 1st Session
Meeting 38
Tuesday, November 22, 2022, 3:52 p.m. to 5:56 p.m.
Webcast
Presiding
Francis Scarpaleggia, Chair (Liberal)

Expand AllCollapse All
• Bob Benzen for Robert Kitchen (Conservative)
• Marty Morantz for Gérard Deltell (Conservative)
Library of Parliament
• Alison Clegg, Analyst
• Robert Mason, Analyst
Bill S-5, An Act to amend the Canadian Environmental Protection Act, 1999, to make related amendments to the Food and Drugs Act and to repeal the Perfluorooctane Sulfonate Virtual Elimination Act
Association québécoise des médecins pour l'environnement
• Dr. Claudel Pétrin-Desrosiers, Family Doctor and President
Canadian Association of Physicians for the Environment
• Dr. Jane E. McArthur, Director, Toxics Program
• Melissa Daniels, Manager, Toxics Program
David Suzuki Foundation
• Lisa Gue, Manager, National Policy
Dow Canada
• W. Scott Thurlow, Senior Advisor, Government Affairs
Ecojustice
• Dr. Elaine MacDonald, Program Director, Healthy Communities
Environmental Defence Canada
• Cassie Barker, Senior Program Manager, Toxics
Pursuant to the order of reference of Thursday, November 3, 2022, the committee commenced consideration of Bill S-5, An Act to amend the Canadian Environmental Protection Act, 1999, to make related amendments to the Food and Drugs Act and to repeal the Perfluorooctane Sulfonate Virtual Elimination Act.

Claudel Pétrin-Desrosiers, Cassie Barker and Lisa Gue made statements and answered questions.

At 4:53 p.m., the sitting was suspended.

At 4:56 p.m., the sitting resumed.

Melissa Daniels, W. Scott Thurlow and Elaine MacDonald made statements and, with Jane E. McArthur, answered questions.

At 5:56 p.m., the committee adjourned to the call of the Chair.



Alexandre Longpré
Clerk of the committee